LAUREN SARACINO: Open Payments
NPI 1336363621 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 44 payments from 13 companies in 2025. Trend: 2023 $825 · 2024 $799 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $124 |
| Amgen Inc. | 6 | $94 |
| Edwards Lifesciences Corporation | 3 | $59 |
| SCPHARMACEUTICALS INC. | 2 | $47 |
| Novo Nordisk Inc | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| BIOTRONIK INC. | 1 | $33 |
| PFIZER INC. | 2 | $29 |
| Abbott Laboratories | 1 | $23 |
Products named: LEQVIO, JARDIANCE, REPATHA, FUROSCIX, SAPIEN 3 Ultra RESILIA, Wegovy, VERQUVO, BIOMONITOR.
Industry payments across NJ — which companies pay providers there.
